Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25077591 |
US |
||
Drug ineffective, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 502 | 25077690 |
US |
39 | 2 |
Breast cancer, Mastectomy, Breast reconstruction, Sepsis, Neoplasm malignant, Pain, Ear infection, Mastectomy, Therapy interrupted, Intentional product use issue, Inability to afford medication, Adverse event, Inability to afford medication, |
||||
| 503 | 25077803 |
GB |
||
Spinal column injury, Fall, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 504 | 25078196 |
US |
76 | 1 |
Therapy interrupted, Product prescribing issue, |
||||
LENALIDOMIDE, |
||||
| 505 | 25078267 |
US |
27 | 1 |
Insurance issue, Therapy interrupted, Progressive multiple sclerosis, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 506 | 25078565 |
80 | 1 | |
Neutrophil count decreased, Therapy change, Therapy interrupted, |
||||
DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 507 | 25078575 |
2 | ||
Therapy interrupted, |
||||
AZELASTINE, CINNAMON, BRIMONIDINE TARTRATE, TIMOLOL MALEATE, LORATADINE, LORATADINE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DENOSUMAB, |
||||
| 508 | 25079073 |
US |
52 | 2 |
Behcet^s syndrome, Cholecystectomy, Hernia, Stoma prolapse, Therapy interrupted, |
||||
APREMILAST, APREMILAST, |
||||
| 509 | 25079221 |
2 | ||
Sickle cell anaemia with crisis, Therapy interrupted, Influenza, |
||||
L-GLUTAMINE, |
||||
| 510 | 25079566 |
57 | 2 | |
Renal injury, Therapy interrupted, Nonspecific reaction, |
||||
ABEMACICLIB, AMLODIPINE, ANASTROZOLE, ANASTROZOLE TABLETS, FAMOTIDINE, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OLANZAPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE, |
||||
| 511 | 25079605 |
CA |
62 | 1 |
Therapy interrupted, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 512 | 25079767 |
CA |
78 | 2 |
Carpal tunnel syndrome, Dry eye, Epistaxis, Eye discharge, Oropharyngeal pain, Productive cough, Respiratory tract congestion, Nasal congestion, Blood pressure increased, Nasopharyngitis, Intentional dose omission, Therapy interrupted, Product distribution issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CALCIUM, CARBIDOPA, CARBIDOPA TABLETS, CARBIDOPA, CARBIDOPA TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, ERGOCALCIFEROL, |
||||
| 513 | 25079775 |
US |
68 | 1 |
Product prescribing issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 514 | 25079846 |
US |
69 | 2 |
Joint swelling, Arthralgia, Insurance issue, Therapy interrupted, |
||||
ABATACEPT, ABATACEPT, |
||||
| 515 | 25079868 |
US |
79 | 2 |
Dyspnoea, Therapy interrupted, Inability to afford medication, |
||||
MAVACAMTEN, FLUTICASONE FUROATE, SEMAGLUTIDE, BIFIDOBACTERIUM BIFIDUM, OIL, BIOTIN, HAIR, MAGNESIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CHLORTHALIDONE, AMILORIDE HYDROCHLORIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, FENOFIBRATE, EZETIMIBE, PITAVASTATIN CALCIUM, PITAVASTATIN, FAMOTIDINE, FOLIC ACID, METOPROLOL TARTRATE, METOPROLOL, ORAL SEMAGLUTIDE, LEVOTHYROXINE SODIUM, DIAZEPAM, PITAVASTATIN CALCIUM, LATANOPROST, MAGNESIUM OXIDE, PANTOPRAZOLE, |
||||
| 516 | 25080036 |
US |
2 | |
Rheumatoid arthritis, Insurance issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 517 | 25083470 |
54 | 2 | |
Pneumonia, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 518 | 25083540 |
2 | ||
Therapy interrupted, Pain, Product use issue, |
||||
GUSELKUMAB, |
||||
| 519 | 25083542 |
64 | 1 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 520 | 25083725 |
2 | ||
Arthralgia, Joint swelling, Kidney infection, Therapy interrupted, |
||||
ADALIMUMAB-BWWD, |
||||
| 521 | 25083750 |
65 | 1 | |
Respiratory syncytial virus infection, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 522 | 25083996 |
2 | ||
Pneumonia, Therapy interrupted, |
||||
LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 523 | 25084041 |
2 | ||
Fall, Head injury, Therapy interrupted, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 524 | 25085089 |
57 | 2 | |
Fluid retention, Therapy interrupted, |
||||
AMBRISENTAN, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ROSUVASTATIN CALCIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LORAZEPAM, TADALAFIL, |
||||
| 525 | 25071625 |
US |
74 | 1 |
Constipation, Drug dose omission by device, Device difficult to use, Migraine, Wrong technique in product usage process, Therapy interrupted, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, |
||||
| 526 | 25072080 |
US |
||
Pain, Therapy interrupted, |
||||
BUROSUMAB, |
||||
| 527 | 25072135 |
BR |
2 | |
Product adhesion issue, Therapy interrupted, |
||||
ROTIGOTINE, |
||||
| 528 | 25072973 |
US |
34 | 2 |
Generalised tonic-clonic seizure, Therapy interrupted, |
||||
EPINEPHRINE, ADRENALINUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 529 | 25073063 |
CO |
45 | 1 |
Surgery, Fibula fracture, Skin abrasion, Road traffic accident, Rash, Arthralgia, Off label use, Therapy interrupted, Product prescribing issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, LOSARTAN, METOPROLOL TARTRATE, METOPROLOL, PRAZOSIN, |
||||
| 530 | 25073175 |
US |
42 | 1 |
Hospitalisation, Generalised tonic-clonic seizure, Postictal state, Therapy interrupted, Overdose, |
||||
BRIVARACETAM, |
||||
| 531 | 25073216 |
US |
81 | 1 |
Peripheral swelling, Product supply issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 532 | 25073766 |
IT |
10 | 2 |
Therapy interrupted, Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 533 | 25074222 |
56 | 2 | |
Medical procedure, Therapy interrupted, |
||||
DROXIDOPA, FLUTICASONE PROPIONATE AND SALMETEROL, ERENUMAB-AOOE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, FAMOTIDINE, RIVAROXABAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 534 | 25074227 |
US |
2 | |
Product use issue, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 535 | 25074447 |
40 | 1 | |
Dizziness, Nausea, Abdominal pain, Constipation, Asthenia, Incorrect dose administered, Therapy interrupted, |
||||
BOSUTINIB, ALLOPURINOL, |
||||
| 536 | 25074485 |
US |
63 | 1 |
Appendicectomy, Lower respiratory tract infection, Sputum retention, Dizziness, Cough, Dyspnoea, Therapy interrupted, Product dose omission issue, |
||||
AMIKACIN, AMIKACIN, |
||||
| 537 | 25074624 |
82 | 2 | |
Ear infection, Therapy interrupted, Inappropriate schedule of product administration, |
||||
ETANERCEPT, |
||||
| 538 | 25074691 |
66 | 2 | |
Pneumonia, Therapy interrupted, |
||||
AVACOPAN, AVACOPAN, |
||||
| 539 | 25074966 |
CA |
28 | 2 |
COVID-19, Intentional dose omission, Product availability issue, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, MOMETASONE FUROATE, MOMETASONE, |
||||
| 540 | 25075153 |
63 | 2 | |
Gastroenteritis viral, Therapy interrupted, |
||||
TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 541 | 25075190 |
55 | 2 | |
Bronchitis, Therapy interrupted, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 542 | 25075195 |
US |
74 | 1 |
Product prescribing issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, SIMVASTATIN, LORATADINE, LORATADINE ORAL, LOSARTAN, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, GABAPENTIN, |
||||
| 543 | 25075360 |
US |
2 | |
Therapy interrupted, |
||||
ERENUMAB-AOOE, |
||||
| 544 | 25075474 |
US |
69 | 1 |
Musculoskeletal stiffness, Renal disorder, Fatigue, Nausea, Constipation, Dyspnoea, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, |
||||
| 545 | 25075552 |
2 | ||
Erythema, Pruritus, Skin burning sensation, Therapy interrupted, Osteomyelitis, |
||||
IXEKIZUMAB, BENRALIZUMAB, |
||||
| 546 | 25075747 |
27 | 2 | |
Cardiogenic shock, Heart transplant, Therapy interrupted, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LOSARTAN, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, EMPAGLIFLOZIN, |
||||
| 547 | 25075906 |
US |
||
Death, Therapy interrupted, |
||||
VUTRISIRAN, |
||||
| 548 | 25076057 |
CA |
32 | 2 |
Influenza like illness, COVID-19, Small intestine ulcer, Crohn^s disease, Product dose omission issue, Therapy interrupted, Intentional dose omission, Incorrect dose administered, Wrong technique in product usage process, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ESZOPICLONE, LEVOTHYROXINE SODIUM, |
||||
| 549 | 25076385 |
US |
29 | 1 |
Therapy interrupted, |
||||
DEUCRAVACITINIB, CLONIDINE, PIMOZIDE, CICLOPIROX OLAMINE, LITHIUM CARBONATE, TRIHEXYPHENIDYL HYDROCHLORIDE, OLANZAPINE, DIVALPROEX SODIUM, ATENOLOL, |
||||
| 550 | 25076470 |
US |
47 | 1 |
Psoriatic arthropathy, Therapy interrupted, Product availability issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 551 | 25076676 |
US |
59 | 1 |
Thrombosis, Lethargy, Confusional state, Therapy interrupted, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 552 | 25076686 |
US |
65 | 2 |
Malaise, Insomnia, Fatigue, Therapy interrupted, Inability to afford medication, Insurance issue, |
||||
LORAZEPAM, LORAZEPAM, LORAZEPAM, |
||||
| 553 | 25076724 |
US |
||
Cataract, Hot flush, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, AMLODIPINE BESYLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ERGOCALCIFEROL, TAMSULOSIN HYDROCHLORIDE, VITAMIN C, DICLOFENAC SODIUM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 554 | 25078371 |
2 | ||
Pulmonary arterial hypertension, Therapy interrupted, Adrenal neoplasm, |
||||
SOTATERCEPT-CSRK, |
||||
| 555 | 25078376 |
2 | ||
Hospitalisation, Therapy interrupted, |
||||
PIRFENIDONE, |
||||
| 556 | 25078421 |
67 | 1 | |
Peripheral swelling, Deep vein thrombosis, Musculoskeletal pain, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 557 | 25078425 |
67 | 1 | |
Musculoskeletal pain, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 558 | 25066083 |
US |
1 | |
Illness, Malaise, Therapy interrupted, Product dose omission in error, Off label use, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 559 | 25066122 |
US |
61 | 2 |
Rheumatoid arthritis, Stress, Product availability issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 560 | 25066125 |
US |
1 | |
Therapy interrupted, |
||||
EVOLOCUMAB, |
||||
| 561 | 25066149 |
US |
||
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 562 | 25066243 |
US |
77 | 1 |
Therapy interrupted, Living in residential institution, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 563 | 25066484 |
US |
76 | 1 |
Therapy interrupted, Product distribution issue, |
||||
LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 564 | 25066592 |
US |
||
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 565 | 25066944 |
US |
||
Symptom recurrence, Product distribution issue, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 566 | 25066990 |
US |
||
Therapy interrupted, Product distribution issue, |
||||
INFLIXIMAB-DYYB, |
||||
| 567 | 25067004 |
US |
75 | 1 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 568 | 25067005 |
US |
||
Therapy interrupted, Device malfunction, |
||||
INFLIXIMAB-DYYB, |
||||
| 569 | 25067042 |
US |
||
Increased appetite, Frequent bowel movements, Abdominal pain, Nausea, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 570 | 25067215 |
US |
||
Vomiting, Therapy interrupted, Underdose, |
||||
ESLICARBAZEPINE ACETATE, ESLICARBAZEPINE ACETATE, ESLICARBAZEPINE ACETATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 571 | 25067584 |
US |
67 | 1 |
Therapy interrupted, Product distribution issue, |
||||
| 572 | 25067715 |
US |
62 | 1 |
Product prescribing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 573 | 25067852 |
US |
||
Prostatic specific antigen increased, Therapy interrupted, |
||||
RELUGOLIX, ALENDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, IPRATROPIUM BROMIDE, LISINOPRIL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, PRIMIDONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, EMPAGLIFLOZIN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, OXYGEN, 0XYGEN, |
||||
| 574 | 25068400 |
1 | ||
Neoplasm malignant, Therapy interrupted, |
||||
OFATUMUMAB, |
||||
| 575 | 25068408 |
2 | ||
Diarrhoea, Therapy interrupted, |
||||
LENALIDOMIDE, IXAZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 576 | 25068444 |
1 | ||
Cholelithiasis, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 577 | 25068906 |
US |
13 | 2 |
Therapy interrupted, |
||||
FILGRASTIM, |
||||
| 578 | 25069191 |
US |
42 | 1 |
Therapeutic product effect decreased, Gouty tophus, Therapy interrupted, |
||||
PEGLOTICASE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 579 | 25069377 |
59 | 2 | |
Cardiac failure chronic, Injection site reaction, Injection site bruising, Therapy interrupted, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, |
||||
| 580 | 25069391 |
VA |
||
Bile acids increased, Scratch, Pruritus, Therapy interrupted, Product temperature excursion issue, |
||||
URSODIOL, URSOSIOL, |
||||
| 581 | 25069404 |
CO |
72 | |
Anosmia, Taste disorder, Disorientation, Deafness, Tooth loss, Therapy interrupted, Depressed mood, |
||||
ACALABRUTINIB, |
||||
| 582 | 25069697 |
US |
2 | |
Hospitalisation, Malaise, Intentional dose omission, Product dose omission issue, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, |
||||
| 583 | 25069717 |
2 | ||
Electrocardiogram abnormal, Heart rate increased, Therapy interrupted, |
||||
APREMILAST, |
||||
| 584 | 25070016 |
US |
62 | 2 |
Joint swelling, Arthralgia, Insurance issue, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 585 | 25070024 |
US |
||
Weight increased, Therapy interrupted, |
||||
BUROSUMAB, |
||||
| 586 | 25070102 |
US |
37 | 1 |
Psoriatic arthropathy, Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 587 | 25070176 |
GB |
2 | |
Hidradenitis, Therapy interrupted, Product distribution issue, |
||||
BIMEKIZUMAB, |
||||
| 588 | 25070248 |
69 | 1 | |
Dyspnoea, Therapy interrupted, |
||||
MACITENTAN, |
||||
| 589 | 25070372 |
US |
1 | |
Death, Disease recurrence, Therapy interrupted, |
||||
| 590 | 25070388 |
US |
70 | 1 |
Hospitalisation, Confusional state, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 591 | 25070972 |
CA |
38 | 2 |
Neutropenia, Autoimmune disorder, Therapy interrupted, Leukopenia, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 592 | 25071008 |
US |
||
Adverse drug reaction, Therapy interrupted, |
||||
ISOTRETINOIN, |
||||
| 593 | 25071327 |
US |
72 | 1 |
Renal impairment, Back pain, Arthropathy, Weight decreased, Fatigue, Nausea, Constipation, Product distribution issue, Therapy interrupted, Coronavirus infection, |
||||
LENALIDOMIDE, |
||||
| 594 | 25073271 |
63 | 1 | |
Product availability issue, Therapy interrupted, |
||||
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 595 | 25073632 |
85 | 1 | |
Infusion related reaction, Tremor, Back pain, Tachycardia, Therapy interrupted, |
||||
OBINUTUZUMAB, VENETOCLAX, |
||||
| 596 | 25073699 |
77 | 2 | |
Unevaluable event, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 597 | 25073782 |
81 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 598 | 25073815 |
58 | 2 | |
Respiratory tract infection, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 599 | 25073828 |
68 | 2 | |
Infection, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 600 | 25073941 |
1 | ||
Malaise, Hepatic enzyme increased, Pyrexia, Chills, Nausea, Vomiting, Tremor, Red blood cell count decreased, Transfusion, Therapy interrupted, |
||||
SOTORASIB, SOTORASIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28